Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn NIH transition notice appears above the ClinicalTrials.gov page, while the study record still displays a 403 Forbidden error. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe displayed site revision changes from v3.7.0 to v3.7.1 while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now returns a 403 Forbidden error, removing the detailed study content and documents from view. A minimal 403 page with site navigation is displayed instead.SummaryDifference16%

- Check55 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page metadata. This change does not modify the study content or how users interact with the page.SummaryDifference0.1%

- Check69 days agoChange DetectedA new page revision entry was added: Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page or site metadata without altering study content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.